Literature DB >> 21833756

Silencing of CD44 by siRNA suppressed invasion, migration and adhesion to matrix, but not secretion of MMPs, of cholangiocarcinoma cells.

Pongsanat Pongcharoen1, Artit Jinawath, Rutaiwan Tohtong.   

Abstract

We studied the expression pattern and the role of CD44 in regulating the malignant behavior of two cholangiocarcinoma (CCA) cell lines which expressed different levels of CD44 using the siRNA technique. KKU-100, the high CD44 expresser, exhibited a high degree of in vitro invasiveness, migration and adhesion to Matrigel compared to HuCCA-1. Silencing of CD44 by siRNA did not have a significant effect on cell proliferation. However, in vitro invasiveness, directional migration (chemotaxis) and adhesion to Matrigel were markedly reduced in both cell lines, although chemokinesis and MMP secretion were variable, demonstrating the distinct functional role and requirement for CD44 in different cellular activities and in different cell types. In addition, immunohistochemical analysis suggested that CD44 may be involved in the differentiation process or tumor progression, depending on the macroscopic type of CCA. Taken together, our data indicate that CD44 is an important requirement for the invasive phenotype of CCA cells, although the role that CD44 plays may vary depending on the CCA type and the cellular activity in which it is engaged.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21833756     DOI: 10.1007/s10585-011-9414-8

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  44 in total

1.  Alpha-V-dependent outside-in signaling is required for the regulation of CD44 surface expression, MMP-2 secretion, and cell migration by osteopontin in human melanoma cells.

Authors:  V Samanna; H Wei; D Ego-Osuala; M A Chellaiah
Journal:  Exp Cell Res       Date:  2006-04-24       Impact factor: 3.905

2.  Polarization and directed migration of murine neutrophils is dependent on cell surface expression of CD44.

Authors:  Per Alstergren; Baoqian Zhu; Michael Glogauer; Michael Glougauer; Tak W Mak; Richard P Ellen; Jaro Sodek
Journal:  Cell Immunol       Date:  2004 Sep-Oct       Impact factor: 4.868

Review 3.  CD44 in inflammation and metastasis.

Authors:  J Lesley; R Hyman; N English; J B Catterall; G A Turner
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

4.  Progressive loss of CD44 gene expression in invasive bladder cancer.

Authors:  T Sugino; H Gorham; K Yoshida; J Bolodeoku; V Nargund; D Cranston; S Goodison; D Tarin
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

Review 5.  CD44 cell adhesion molecules.

Authors:  S Goodison; V Urquidi; D Tarin
Journal:  Mol Pathol       Date:  1999-08

Review 6.  Intrahepatic cholangiocarcinoma: macroscopic type and stage classification.

Authors:  Susumu Yamasaki
Journal:  J Hepatobiliary Pancreat Surg       Date:  2003

7.  Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.

Authors:  Alfredo Guglielmi; Andrea Ruzzenente; Tommaso Campagnaro; Silvia Pachera; Alessandro Valdegamberi; Paola Nicoli; Alessandro Cappellani; Giulio Malfermoni; Calogero Iacono
Journal:  World J Surg       Date:  2009-06       Impact factor: 3.352

8.  Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion.

Authors:  Q Yu; I Stamenkovic
Journal:  Genes Dev       Date:  1999-01-01       Impact factor: 11.361

9.  Osteopontin modulates CD44-dependent chemotaxis of peritoneal macrophages through G-protein-coupled receptors: evidence of a role for an intracellular form of osteopontin.

Authors:  Baoqian Zhu; Keiko Suzuki; Harvey A Goldberg; Susan R Rittling; David T Denhardt; Christopher A G McCulloch; Jaro Sodek
Journal:  J Cell Physiol       Date:  2004-01       Impact factor: 6.384

10.  Chemotaxis towards hyaluronan is dependent on CD44 expression and modulated by cell type variation in CD44-hyaluronan binding.

Authors:  George Tzircotis; Rick F Thorne; Clare M Isacke
Journal:  J Cell Sci       Date:  2005-10-18       Impact factor: 5.285

View more
  12 in total

1.  Clinicopathologic significance of Sox2, CD44 and CD44v6 expression in intrahepatic cholangiocarcinoma.

Authors:  Mi Jin Gu; Byung Ik Jang
Journal:  Pathol Oncol Res       Date:  2014-01-31       Impact factor: 3.201

2.  Dihydrotanshinone I Enhances Cell Adhesion and Inhibits Cell Migration in Osteosarcoma U-2 OS Cells through CD44 and Chemokine Signaling.

Authors:  Lanyan Fan; Chen Peng; Xiaoping Zhu; Yawen Liang; Tianyi Xu; Peng Xu; Shihua Wu
Journal:  Molecules       Date:  2022-06-09       Impact factor: 4.927

3.  WTAP regulates migration and invasion of cholangiocarcinoma cells.

Authors:  Hong-Jae Jo; Hye-Eun Shim; Myoung-Eun Han; Hyun-Jung Kim; Ki-Sun Kim; Sungmin Baek; Kyung-Un Choi; Gi-Yeong Hur; Sae-Ock Oh
Journal:  J Gastroenterol       Date:  2013-01-25       Impact factor: 7.527

4.  CD44+ gastric cancer cells with stemness properties are chemoradioresistant and highly invasive.

Authors:  Mao Sun; Wei Zhou; Yun-Yun Zhang; Dong-Lin Wang; Xiao-Ling Wu
Journal:  Oncol Lett       Date:  2013-03-26       Impact factor: 2.967

5.  CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment.

Authors:  Malinee Thanee; Watcharin Loilome; Anchalee Techasen; Eiji Sugihara; Shogo Okazaki; Shinya Abe; Shiho Ueda; Takashi Masuko; Nisana Namwat; Narong Khuntikeo; Attapol Titapun; Chawalit Pairojkul; Hideyuki Saya; Puangrat Yongvanit
Journal:  Cancer Sci       Date:  2016-06-20       Impact factor: 6.716

6.  Gadd45β silencing impaired viability and metastatic phenotypes in cholangiocarcinoma cells by modulating the EMT pathway.

Authors:  Kyaw Zwar Myint; Pornparn Kongpracha; Panthip Rattanasinganchan; Kawin Leelawat; Penpak Moolthiya; Kittipong Chaiyabutr; Rutaiwan Tohtong
Journal:  Oncol Lett       Date:  2017-12-28       Impact factor: 2.967

7.  Multi-factorial modulation of colorectal carcinoma cells motility - partial coordination by the tetraspanin Co-029/tspan8.

Authors:  Yingying Zhu; Naouel Ailane; Monica Sala-Valdés; Farhad Haghighi-Rad; Martine Billard; Viet Nguyen; Raphael Saffroy; Antoinette Lemoine; Eric Rubinstein; Claude Boucheix; Céline Greco
Journal:  Oncotarget       Date:  2017-04-18

8.  Sulfasalazine could modulate the CD44v9-xCT system and enhance cisplatin-induced cytotoxic effects in metastatic bladder cancer.

Authors:  Koichiro Ogihara; Eiji Kikuchi; Shogo Okazaki; Masayuki Hagiwara; Toshikazu Takeda; Kazuhiro Matsumoto; Takeo Kosaka; Shuji Mikami; Hideyuki Saya; Mototsugu Oya
Journal:  Cancer Sci       Date:  2019-03-01       Impact factor: 6.716

9.  HPV16 oncoproteins promote cervical cancer invasiveness by upregulating specific matrix metalloproteinases.

Authors:  Jittranan Kaewprag; Wareerat Umnajvijit; Jarunya Ngamkham; Mathurose Ponglikitmongkol
Journal:  PLoS One       Date:  2013-08-13       Impact factor: 3.240

10.  In vivo monitoring of CD44+ cancer stem-like cells by γ-irradiation in breast cancer.

Authors:  Mi Hyun Kim; Min Hwan Kim; Kwang Seok Kim; Myung-Jin Park; Jae-Hoon Jeong; Seung Woo Park; Young Hoon Ji; Kwang Il Kim; Tae Sup Lee; Phil Youl Ryu; Joo Hyun Kang; Yong Jin Lee
Journal:  Int J Oncol       Date:  2016-04-18       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.